{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:50:33Z","timestamp":1791449433525,"version":"4.3.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13555-026-01874-z","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:36:06Z","timestamp":1786728966000},"page":"4961-4974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dermatologists\u2019 Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates"],"prefix":"10.1007","volume":"16","author":[{"given":"Fatima","family":"Albreiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7104-387X","authenticated-orcid":false,"given":"Ayman Ahmed Essa","family":"Al Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna Mohamed","family":"Al Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pervaz Ahmad","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-3317","authenticated-orcid":false,"given":"Haytham Mohamed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diala","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Azrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-7712","authenticated-orcid":false,"given":"Gerardo A.","family":"Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8484-6251","authenticated-orcid":false,"given":"Ashley S.","family":"Cha-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-5304","authenticated-orcid":false,"given":"Shailja","family":"Vaghela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2095-5096","authenticated-orcid":false,"given":"Juliana Machado","family":"Canosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"2","key":"1874_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","volume":"14","author":"N Islam","year":"2015","unstructured":"Islam N, Leung PS, Huntley AC, et al. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.014.","journal-title":"Autoimmun Rev"},{"key":"1874_CR2","doi-asserted-by":"publisher","first-page":"7194270","DOI":"10.1155\/2020\/7194270[publishedOnlineFirst:20200313]","volume":"2020","author":"AA Alshahrani","year":"2020","unstructured":"Alshahrani AA, Al-Tuwaijri R, Abuoliat ZA, et al. Prevalence and clinical characteristics of alopecia areata at a tertiary care center in Saudi Arabia. Dermatol Res Pract. 2020;2020:7194270. https:\/\/doi.org\/10.1155\/2020\/7194270[publishedOnlineFirst:20200313].","journal-title":"Dermatol Res Pract"},{"key":"1874_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/CCID.S53985","volume":"8","author":"AC Villasante Fricke","year":"2015","unstructured":"Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397\u2013403. https:\/\/doi.org\/10.2147\/CCID.S53985.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"1874_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jaad.2016.04.035","volume":"75","author":"LY Liu","year":"2016","unstructured":"Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review. J Am Acad Dermatol. 2016;75(4):806-12.e3. https:\/\/doi.org\/10.1016\/j.jaad.2016.04.035.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"1874_CR5","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s13555-025-01546-4","volume":"15","author":"HA Dayem","year":"2025","unstructured":"Dayem HA, Al Hammadi A, Reda A, et al. The burden of alopecia areata and management with baricitinib in the United Arab Emirates: a narrative review. Dermatol Ther. 2025;15(12):3463\u201377. https:\/\/doi.org\/10.1007\/s13555-025-01546-4.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"9","key":"1874_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/1346-8138.17381","volume":"51","author":"AA Hammadi","year":"2024","unstructured":"Hammadi AA, Parmar NV, Farghaly M, et al. A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database. J Dermatol. 2024;51(9):1157\u201371. https:\/\/doi.org\/10.1111\/1346-8138.17381.","journal-title":"J Dermatol"},{"issue":"3","key":"1874_CR7","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s13555-026-01665-6","volume":"16","author":"CC Chen","year":"2026","unstructured":"Chen CC, Yang CC, Lin SJ, et al. Dermatologists\u2019 perspectives and real-world assessment of alopecia areata severity in adults in Taiwan: a cross-sectional survey. Dermatol Ther (Heidelb). 2026;16(3):1693\u2013705. https:\/\/doi.org\/10.1007\/s13555-026-01665-6.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"1874_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1346-8138.16360","volume":"49","author":"E Edson-Heredia","year":"2022","unstructured":"Edson-Heredia E, Aranishi T, Isaka Y, et al. Patient and physician perspectives on alopecia areata: a real-world assessment of severity and burden in Japan. J Dermatol. 2022;49(6):575\u201383. https:\/\/doi.org\/10.1111\/1346-8138.16360.","journal-title":"J Dermatol"},{"issue":"11","key":"1874_CR9","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372. https:\/\/doi.org\/10.1185\/03007990802457040.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"1874_CR10","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, et al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315. https:\/\/doi.org\/10.1080\/03007995.2023.2279679.","journal-title":"Curr Med Res Opin"},{"key":"1874_CR11","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s13555-026-01773-3","volume":"16","author":"SK Kurosky","year":"2026","unstructured":"Kurosky SK, Cha-Silva AS, Austin J, et al. Real-world ritlecitinib treatment of severe alopecia areata in the United States: patient characteristics and physician satisfaction according to a secondary database analysis. Dermatol Ther (Heidelb). 2026. https:\/\/doi.org\/10.1007\/s13555-026-01773-3.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"1874_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s13555-022-00702-4","volume":"12","author":"HL Gelhorn","year":"2022","unstructured":"Gelhorn HL, Cutts K, Edson-Heredia E, et al. The relationship between patient-reported severity of hair loss and health-related quality of life and treatment patterns among patients with alopecia areata. Dermatol Ther (Heidelb). 2022;12(4):989\u201397. https:\/\/doi.org\/10.1007\/s13555-022-00702-4.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"1874_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1874_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365. https:\/\/doi.org\/10.2165\/00019053-199304050-00006.","journal-title":"Pharmacoeconomics"},{"key":"1874_CR15","unstructured":"LITFULO (ritlecitinib). Prescribing Information. 2023. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19638. Accessed March 2024."},{"key":"1874_CR16","unstructured":"OLUMIANT (baricitinib). Prescribing Information. 2022. https:\/\/pi.lilly.com\/us\/olumiant-uspi.pdf. Accessed Nov 9, 2022."},{"issue":"4","key":"1874_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/bjd.18883","volume":"183","author":"KW Wyrwich","year":"2020","unstructured":"Wyrwich KW, Kitchen H, Knight S, et al. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials. Br J Dermatol. 2020;183(4):702\u20139. https:\/\/doi.org\/10.1111\/bjd.18883.","journal-title":"Br J Dermatol"},{"key":"1874_CR18","unstructured":"The Alopecia Areata Scale (AASc) A multidimensional tool for assessing severity of AA olumiant.lilly.com: Lilly; 2024. https:\/\/olumiant.lilly.com\/assets\/pdf\/AA-HCP%20AASc%20Resource%202024.pdf. Accessed Jan 6, 2025."},{"key":"1874_CR19","doi-asserted-by":"crossref","unstructured":"Shapiro J, Ko J, Egeberg A, et al. Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase\u00a03 trials of baricitinib for alopecia areata. AAD 2023. New Orleans, LA, USA: eposters.aad.org, 2023.","DOI":"10.1016\/j.jaad.2023.07.511"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01874-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01874-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01874-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:00:20Z","timestamp":1791446420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01874-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01874-z","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mostafa Zayed, Haytham Mohamed Ahmed, Diala Hamza, Zeina Azrak, Samantha K. Kurosky, Gerado A. Encinas, Ashley S. Cha-Silva, and Juliana Machado Canosa are employees of and may hold stock or stock options in Pfizer Inc or Pfizer Brasil Ltda. Peter Anderson is an employee of Adelphi Real World. Shailja Vaghela is an employee of HealthEcon Consulting, Inc., which was a paid contractor to Pfizer in connection with the development of this manuscript and contributed to the design of this study. Fatima El Beriki, Ayman Ahmed Essa Al Naeem, Muna Mohamed Al Safi, Ahmed Ameen, and Pervaz Ahmad Mohammad declare no conflicts.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines, and as such this study does not require ethics committee approval. The study protocol was reviewed by the Western Institutional Review Board and deemed to be exempt. The study was also conducted in accordance with the International Council for Harmonization Guideline for Good Clinical Practice and the Declaration of Helsinki. The results and views expressed in\u00a0this article may not represent the official position of each author\u2019s affiliated institution.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}